Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United States
Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, proudly announces that the U.S. Food and Drug Administration (FDA) has approved Obagi saypha® MagIQ™ injectable hyaluronic acid (HA) gel.
